Evidence map›Paper›PMID 42196377›Full record

ArticleInternational journal of molecular sciences2026

Integrated Network Pharmacology and Gut Microbiota Analysis Reveals the Alcoholic Extract of

Hao Yang, Lijuan Zhang, Xinle Tang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hao YangSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Lijuan ZhangSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Xinle TangSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.

Funding

Science and Technology Department of Xinjiang Uyghur Autonomous Region No.2024TSYCQNTJ0039
6 · The paper itself

Abstract

The global incidence of nonalcoholic fatty liver disease (NAFLD) is rising, with no approved pharmacotherapy available. Medicinal plants offer a potential preventive strategy.

Indexed as

Gastrointestinal MicrobiomeNF-kappa BNon-alcoholic Fatty Liver DiseasePlant ExtractsPlant RootsRosaceaeToll-Like Receptor 4AnimalsDiet, High-FatLipopolysaccharidesLiverMaleMiceMice, Inbred C57BLNetwork PharmacologySignal TransductionLipopolysaccharidesNF-kappa BPlant ExtractsToll-Like Receptor 4Anacyclus pyrethrum root ethanol extractglucose and lipid metabolism disordersgut microbiotahigh-fat dietnon-alcoholic fatty liver disease

Identifiers

PMID42196377
PMCPMC13207582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.